Abstract
Corticotropin-releasing hormone (CRH) is one of the major proteins responsible for brain stress regulation. Two well-known receptors have been described: type 1 and type 2α, both members of the receptor superfamily of G protein-coupled receptors (GPCR). We investigated receptor regulation when both CRH receptor subtypes are coexpressed in the same mammalian cell line. When both types of receptors are coexpressed, cAMP second messenger production is partially inhibited compared to when receptors are expressed separately. However, neither binding kinetics nor internalization rates are modified by coexpression of these receptors. To our knowledge this is the first demonstration of receptor interaction that results in the modification of CRH-mediated signal transduction pathway. Because CRH-R1 and CRH-R2α have overlapping mRNA expression patterns in the brain, these receptors may be coexpressed in neurons, suggesting that receptor interaction may play an important role in the effect evoked by CRH, contributing to the complexity of differential coupling of the CRH receptors in different endocrine and stress behavior responses.
Similar content being viewed by others
References
Vale, W., Spiess, J., Rivier, C., and Rivier, J. (1981). Science 213, 1394–1397.
Dautzenberg, F. M. and Hauger, R. L. (2002). Trends Pharmacol. Sci. 23, 71–77.
Hsu, S. Y. and Hsueh, A. J. W. (2001). Nat. Med. 7, 605–611.
Lewis, K., Li, C., Perrin, M. H., et al. (2001). Proc. Natl. Acad. Sci. USA 98, 7570–7575.
Chang, C. P., Pearse, R. V., 2nd, O’Connell, S., and Rosenfeld, M. G. (1993). Neuron 11, 1187–1195.
Chen, R., Lewis, K. A., Perrin, M. H., and Vale, W. W. (1993). Proc. Natl. Acad. Sci. USA 90, 8967–8971.
Vita, N., Laurent, P., Lefort, S., et al. (1993). FEBS Lett. 335, 1–5.
Kishimoto, T., Pearse, R.V., 2nd, Lin, C. R., and Rosenfeld, M. G. (1995). Proc. Natl. Acad. Sci. USA 92, 1108–1112.
Lovenberg, T. W., Liaw, C. L., Grigoriadis, D. E., et al. (1995). Proc. Natl. Acad. Sci. USA 92, 836–840.
Perrin, M., Donaldson, C., Chen, R., et al. (1995). Proc. Natl. Acad. Sci. USA 92, 2969–2973.
Potter, E., Sutton, S., Donaldson, C., et al. (1994). Proc. Natl. Acad. Sci. USA 91, 8777–8781.
Chalmers, D. T., Lovenberg, T. W., and De Souza, E. B. (1995). J. Neurosci. 15, 6340–6350.
Hauger, R. L. and Dautzenberg, F. M. (2000). In: Neuroendocrinology in physiology and medicine. Conn, P. M. and Freeman, M. E. (eds.). Human Press: Totowa, NJ.
Ulisse, S., Fabbri, A., Tinajero, J. C., and Dufau, M. L. (1990). J. Biol. Chem. 268, 9–12.
Takuma, K., Matsuda, T., Yoshikawa, T., et al. (1994). Biochem. Biophys. Res. Commun. 199, 1103–1107.
Miyata, M., Okada, D., Hashimoto, K., Kano, M., and Ito, M. (1999). Neuron 22, 763–775.
Dautzenberg, F. M., Gutknecht, E., Van der Linden, I., Olivares-Reyes, J. A., Dürrenberger, F., and Hauger, R. L. (2004). Biochem. Pharmacol. 68, 1833–1844.
Hebert, T. E., Moffett, S., Morello, J. P., et al. (1996). J. Biol. Chem. 271, 16384–16392.
Cvejic, S. and Devi, L. A. (1997). J. Biol. Chem. 272, 26959–26964.
Ng, G. Y., O’Dowd, B. F., Lee, S. P., et al. (1996). Biochem. Biophys. Res. Commun. 227, 200–204.
Nimchinsky, E. A., Hof, P. R., Janssen, W. G., Morrison, J. H., and Schamauss, C. (1997). J. Biol. Chem. 272, 29229–29237.
George, S. R., Lee, S. P., Varghese, G., et al. (1998). J. Biol. Chem. 273, 30244–30248.
Jones, K. A., Borowsky, B., Tamm, J. A., et al. (1998). Nature 396, 674–679.
Kaupmann, K., Malitschek, B., Schuler, V., et al. (1998). Nature 396, 683–687.
White, J. H., Wise, A., Main, M. J., et al. (1998). Nature 396, 679–682.
Kuner, R., Kohr, G., Grunewald, S., Eisenhardt, G., Bach, A., and Kornau, H. C. (1999). Science 283, 74–77.
Chen, F. M., Bilezikjian, L. M., Perrin, M. H., Rivier, J., and Vale, W. (1986). Brain Res. 381, 49–57.
Battaglia, G., Webster, E. L., and De Souza, E. B. (1987). Synapse 1, 572–581.
Pihoker, C., Cain, S. T., and Nemeroff, C. B. (1992). Prog. Neuropsychopharmacol. Biol. Psychiatry 16, 581–586.
Haug, T. and Storm, J. F. (2000). J. Neurophysiol. 83, 2071–2079.
Kroeger, K. M., Pfleger, K. D. G., and Eidne, K. A. (2004). Front. Neuroendocrinol. 24, 254–278.
Gomes, I., Jordan, B. A., Gupta, A., Trapaidze, N., Nagy, V., and Devi, L. A. (2000). J. Neurosci. 20, RC110.
Rocheville, M., Lange, D. C., Kumar, S. C., Patel, S. C., Patel, R. C., and Patel, Y. C. (2000). Science 288, 154–157.
AbdAlla, S., Lother, H., el Massiery, A., and Quitterer, U. (2001). Nat. Med. 7, 1003–1009.
Cornea, A., Janovick, J. A., Maya-Núñez, G., and Conn, P. M. (2001). J. Biol. Chem. 276, 2153–2158.
Pfeiffer, M., Koch, T., Schroder, H., et al. (2001). J. Biol. Chem. 276, 14027–14036.
Lavoie, C., Mercier, J. F., Salahpour, A., et al. (2002). J. Biol. Chem. 277, 35402–35410.
Brady, A. E. and Limbird, L. E. (2002). Cell. Signal 14, 297–309.
Handel, M., Schulz, S., Stanrius, A., et al. (1999). Neuroscience 89, 909–926.
Millian, M. J., Dekeyne, A., Rivet, J. M., Dubuffet, T., Lavielle, G., and Brocco, M. (2000). J. Pharmacol. Exp. Ther. 293, 1063–1073.
Olianas, M. C., Lampis, G., and Onali, P. (1995). J. Neurochem. 64, 402–407.
Hanyaloglu, A. C., Seeber, R. M., Kohout, T. A., Lefkowitz, R. J., and Eidne, K. A. (2002). J. Biol. Chem. 277, 50422–50430.
Guo, W., Shi, L., and Javitch, J. A. (2003). J. Biol. Chem. 278, 4385–4388.
Castro-Fernández, C., Maya-Núñez, G., and Méndez, J. P. (2004). Endocrine 25, 49–54.
Andrews, W. V. and Conn, P. M. (1986). Endocrinology 118, 1148–1158.
Rosendale, B. E., Jarrett, D. B., and Robinson, A. G. (1987). Endocrinology 120, 2357–2366.
Author information
Authors and Affiliations
Corresponding author
Additional information
An erratum to this article is available at http://dx.doi.org/10.1007/s12020-005-0001-0.
Rights and permissions
About this article
Cite this article
Maya-Núñez, G., Castro-Fernández, C. & Méndez, P. CRH-stimulation of cyclic adenosine 5′-monophosphate pathway is partially inhibited by the coexpression of CRH-R1 and CRH-R2α. Endocr 27, 67–73 (2005). https://doi.org/10.1385/ENDO:27:1:067
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ENDO:27:1:067